Tudor Investment Corp’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,978,628
| Closed | -$201M | – | 3816 |
|
|
2025
Q4 | $201M | Buy |
1,978,628
+1,963,700
| +13,154% | +$158M | 0.37% | 31 |
|
|
2025
Q3 | $817K | Sell |
14,928
-33,132
| -69% | -$1.66M | ﹤0.01% | 2403 |
|
|
2025
Q2 | $2.55M | Buy |
48,060
+37,530
| +356% | +$1.91M | 0.01% | 1501 |
|
|
2025
Q1 | $456K | Buy |
+10,530
| New | +$533K | ﹤0.01% | 2339 |
|
|
2023
Q2 | – | Sell |
-9,181
| Closed | -$623K | – | 2577 |
|
|
2023
Q1 | $623K | Buy |
9,181
+429
| +5% | +$27.6K | 0.01% | 1490 |
|
|
2022
Q4 | $433K | Sell |
8,752
-78,722
| -90% | -$3.22M | 0.01% | 1677 |
|
|
2022
Q3 | $2.84M | Buy |
+87,474
| New | +$3.61M | 0.06% | 404 |
|
|
2022
Q2 | – | Sell |
-4,959
| Closed | -$347K | – | 2225 |
|
|
2022
Q1 | $347K | Sell |
4,959
-6,475
| -57% | -$473K | 0.01% | 1470 |
|
|
2021
Q4 | $890K | Sell |
11,434
-15,512
| -58% | -$1.37M | 0.01% | 1075 |
|
|
2021
Q3 | $2.57M | Buy |
+26,946
| New | +$2.85M | 0.04% | 559 |
|
|
2021
Q1 | – | Sell |
-36,256
| Closed | -$4.8M | – | 1642 |
|
|
2020
Q4 | $4.8M | Buy |
+36,256
| New | +$4.38M | 0.14% | 148 |
|
|
2020
Q2 | – | Sell |
-6,948
| Closed | -$403K | – | 1231 |
|
|
2020
Q1 | $403K | Buy |
+6,948
| New | +$564K | 0.04% | 577 |
|
|
2019
Q4 | – | Sell |
-57,690
| Closed | -$5.21M | – | 1208 |
|
|
2019
Q3 | $5.21M | Buy |
+57,690
| New | +$6.57M | 0.18% | 120 |
|
|
2019
Q2 | – | Sell |
-32,103
| Closed | -$2.78M | – | 1164 |
|
|
2019
Q1 | $2.78M | Buy |
+32,103
| New | +$2.73M | 0.12% | 193 |
|
|
2018
Q3 | – | Sell |
-76,583
| Closed | -$4.58M | – | 1128 |
|
|
2018
Q2 | $4.58M | Buy |
76,583
+51,400
| +204% | +$2.77M | 0.16% | 89 |
|
|
2018
Q1 | $1.02M | Buy |
25,183
+19,826
| +370% | +$967K | 0.03% | 325 |
|
|
2017
Q4 | $281K | Buy |
+5,357
| New | +$286K | 0.01% | 834 |
|
|
2017
Q3 | – | Sell |
-28,500
| Closed | -$1.01M | – | 1132 |
|
|
2017
Q2 | $1.01M | Buy |
+28,500
| New | +$880K | 0.03% | 333 |
|
|
2016
Q4 | – | Sell |
-32,756
| Closed | -$608K | – | 1454 |
|
|
2016
Q3 | $608K | Buy |
+32,756
| New | +$577K | 0.01% | 634 |
|
|
2016
Q2 | – | Sell |
-19,436
| Closed | -$131K | – | 1712 |
|
|
2016
Q1 | $131K | Buy |
+19,436
| New | +$124K | ﹤0.01% | 1587 |
|
|
2015
Q1 | – | Sell |
-9,500
| Closed | -$261K | – | 1493 |
|
|
2014
Q4 | $261K | Sell |
9,500
-9,011
| -49% | -$219K | 0.01% | 1123 |
|
|
2014
Q3 | $359K | Buy |
+18,511
| New | +$339K | 0.01% | 889 |
|
|
2014
Q2 | – | Sell |
-11,040
| Closed | -$156K | – | 1208 |
|
|
2014
Q1 | $156K | Buy |
+11,040
| New | +$149K | 0.01% | 1080 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Tudor Investment Corp's EXAS Position: Q1 2026 in Review
Tudor Investment Corp sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,978,628 shares — an estimated $201M sold.
Tudor Investment Corp first reported a position in EXAS in Q1 2014 and held it in 23 quarters. The position peaked at $201M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Tudor Investment Corp reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Tudor Investment Corp sold 1,978,628 Exact Sciences shares in Q1 2026, an estimated $201M.
- Tudor Investment Corp first reported a position in Exact Sciences in Q1 2014 and held it in 23 quarters.
- Tudor Investment Corp's Exact Sciences position peaked at $201M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.